These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8955166)

  • 21. B cells process and present lupus autoantigens that initiate autoimmune T cell responses.
    Mamula MJ; Fatenejad S; Craft J
    J Immunol; 1994 Feb; 152(3):1453-61. PubMed ID: 8301145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urtica dioica agglutinin, a V beta 8.3-specific superantigen, prevents the development of the systemic lupus erythematosus-like pathology of MRL lpr/lpr mice.
    Musette P; Galelli A; Chabre H; Callard P; Peumans W; Truffa-Bachi P; Kourilsky P; Gachelin G
    Eur J Immunol; 1996 Aug; 26(8):1707-11. PubMed ID: 8765010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The systemic and SmD183-119-autoantigen-specific cytokine memory of Th cells in SLE patients.
    Langer S; Langnickel D; Enghard P; Undeutsch R; Burmester GR; Hiepe F; Radbruch A; Riemekasten G
    Rheumatology (Oxford); 2007 Feb; 46(2):238-45. PubMed ID: 16880187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1999 Jan; 162(2):813-20. PubMed ID: 9916703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H; Weill B; Fournier C; Batteux F
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J; Mamula MJ
    Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 9 signaling protects against murine lupus.
    Wu X; Peng SL
    Arthritis Rheum; 2006 Jan; 54(1):336-42. PubMed ID: 16385525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradoxical arrest in lupus activity in BXSB mice with highly autoreactive T cells.
    Stojakovic M; Tatari-Calderone Z; Maric C; Hoang A; Vukmanovic S
    Lupus; 2010 Feb; 19(2):182-91. PubMed ID: 19946033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain.
    Xavier RM; Nakamura M; Tsunematsu T
    J Immunol; 1994 Mar; 152(5):2624-32. PubMed ID: 8133068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice.
    Fujii T; Okada M; Mimori T; Craft J
    Clin Exp Immunol; 2002 Nov; 130(2):224-32. PubMed ID: 12390309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells in murine lupus: propagation and regulation of disease.
    Peng SL; Craft J
    Mol Biol Rep; 1996; 23(3-4):247-51. PubMed ID: 9112236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice.
    Peng SL; Cappadona J; McNiff JM; Madaio MP; Owen MJ; Hayday AC; Craft J
    Clin Exp Immunol; 1998 Jan; 111(1):107-16. PubMed ID: 9472669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease.
    Fujio K; Okamoto A; Tahara H; Abe M; Jiang Y; Kitamura T; Hirose S; Yamamoto K
    J Immunol; 2004 Aug; 173(3):2118-25. PubMed ID: 15265948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of lupus therapy modulating autoantigen recognition.
    Okamoto A; Fujio K; Yamamoto K
    Lupus; 2010 Oct; 19(12):1474-81. PubMed ID: 20947560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in nuclear structure promote lupus autoimmunity in a mouse model.
    Singh N; Johnstone DB; Martin KA; Tempera I; Kaplan MJ; Denny MF
    Dis Model Mech; 2016 Aug; 9(8):885-97. PubMed ID: 27483354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.
    Herlands RA; William J; Hershberg U; Shlomchik MJ
    Eur J Immunol; 2007 Dec; 37(12):3339-51. PubMed ID: 18034429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases.
    Nishimura H; Strominger JL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3292-7. PubMed ID: 16492738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations, legends, and conjectures concerning restricted T-cell receptor usage and autoimmune disease.
    Esch T; Clark L; Zhang XM; Goldman S; Heber-Katz E
    Crit Rev Immunol; 1992; 11(5):249-64. PubMed ID: 1386519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.